EQUEST
PRAMOX contains moxidectin, the unique active ingredient of
EQUEST, and praziquantel, the drug of choice for the control
of tapeworm.
• EQUEST PRAMOX is the only combination
wormer licensed to control small redworms, including the inhibited
and developing encysted small redworm larval stages, as well
as other roundworm species, bots and all three species of
tapeworm.
• EQUEST PRAMOX has the longest
dosing interval of any combination wormer: 13-weeks. The active
ingredient moxidectin prevents the reappearance of roundworm
eggs in the horse’s dung for at least 90 days, which
is longer than any other active (Jacobs
D et al, 1995), (Parr S et al) this gives EQUEST PRAMOX
its 13-week dosing interval.
• EQUEST PRAMOX is easy to administer
in a palatable gel formula. EQUEST PRAMOX melts in your horse’s
mouth to reduce the risk of being spat out. Presented in easy
to use dial-a-dose syringes with 25kg graduations; this allows
accurate dosing according to your horse’s weight. |
|
 |
|
|
•
EQUEST PRAMOX has no confirmed resistance in horses
in the UK or Ireland. EQUEST PRAMOX is licensed to control
the increasingly prevalent benzimidazole (fenbendazole
and mebendazole) resistant strains of small redworm.
Making it a suitable treatment for new horses arriving
at a yard.
• EQUEST PRAMOX is safe to use in horses and
ponies, including stallions and mares*, and is licensed
for use in foals from 6 ½ months.
* Not licensed for use in pregnant and lactating mares.
Advice on the use of this or alternative medicines
must be sought from the medicine prescriber. |
|
| |
| |
|
